1.
Sansone S, Amir Y, Lebwohl M. Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease. J of Skin [Internet]. 2020May8 [cited 2020Nov.25];4(3):256-9. Available from: https://jofskin.org/index.php/skin/article/view/651